Citadel Advisors’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.71M Sell
1,102,600
-1,356,500
-55% -$8.49M ﹤0.01% 4126
2025
Q4
$18M Sell
2,459,100
-237,300
-9% -$2.3M ﹤0.01% 2490
2025
Q3
$26.9M Sell
2,696,400
-868,286
-24% -$9.61M ﹤0.01% 1982
2025
Q2
$32.3M Buy
3,564,686
+493,143
+16% +$3.22M 0.01% 1609
2025
Q1
$19.7M Buy
3,071,543
+734,400
+31% +$6.54M ﹤0.01% 2051
2024
Q4
$22.2M Sell
2,337,143
-427,543
-15% -$3.75M ﹤0.01% 2058
2024
Q3
$22.6M Buy
2,764,686
+64,229
+2% +$667K ﹤0.01% 1918
2024
Q2
$36.5M Buy
2,700,457
+1,178,286
+77% +$9.85M 0.01% 1416
2024
Q1
$10.7M Sell
1,522,171
-297,258
-16% -$2.58M ﹤0.01% 2869
2023
Q4
$19.9M Buy
1,819,429
+85,600
+5% +$840K ﹤0.01% 2019
2023
Q3
$19M Sell
1,733,829
-61,371
-3% -$877K ﹤0.01% 1918
2023
Q2
$28.3M Buy
1,795,200
+762,171
+74% +$8.87M 0.01% 1537
2023
Q1
$13.5M Sell
1,033,029
-118,057
-10% -$969K ﹤0.01% 2425
2022
Q4
$12.5M Buy
1,151,086
+81,600
+8% +$1M ﹤0.01% 2506
2022
Q3
$17.2M Buy
1,069,486
+935,086
+696% +$13.8M ﹤0.01% 2046
2022
Q2
$1.05M Buy
134,400
+50,971
+61% +$479K ﹤0.01% 6912
2022
Q1
$1.04M Sell
83,429
-89,371
-52% -$1.25M ﹤0.01% 7597
2021
Q4
$4.13M Buy
172,800
+34,171
+25% +$827K ﹤0.01% 4678
2021
Q3
$2.29M Buy
138,629
+79,429
+134% +$1.2M ﹤0.01% 6010
2021
Q2
$1.19M Buy
59,200
+34,400
+139% +$467K ﹤0.01% 7890
2021
Q1
$289K Buy
+24,800
New +$326K ﹤0.01% 10942

Other funds holding ENVX

Citadel Advisors's ENVX Position: Q1 2026 in Review

Citadel Advisors increased its Enovix (ENVX) stake by 300% in Q1 2026, buying an estimated $3.69M and bringing the position to 785,329 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4683.

Citadel Advisors first reported a position in ENVX in Q3 2021 and has held it in 18 quarters since. The position peaked at $30.4M in Q2 2024. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • Citadel Advisors held 785,329 shares of Enovix worth $4.07M as of Q1 2026.
  • Citadel Advisors bought 588,873 Enovix shares in Q1 2026, an estimated $3.69M.
  • Enovix made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4683 holding.
  • Citadel Advisors first reported a position in Enovix in Q3 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Enovix position peaked at $30.4M in Q2 2024.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.